These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27987372)

  • 1. SIX1 maintains tumor basal cells via transforming growth factor-β pathway and associates with poor prognosis in esophageal cancer.
    Nishimura T; Tamaoki M; Komatsuzaki R; Oue N; Taniguchi H; Komatsu M; Aoyagi K; Minashi K; Chiwaki F; Shinohara H; Tachimori Y; Yasui W; Muto M; Yoshida T; Sakai Y; Sasaki H
    Cancer Sci; 2017 Feb; 108(2):216-225. PubMed ID: 27987372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis].
    Wei Q; Yu WW; Zhao KL; Fu XL; Zhu ZF; Qin GQ; Chen H; Zhang ZX; Gu YZ; Xiang JQ; Chen HQ; Du X; Sun MH
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):446-50. PubMed ID: 24246862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes.
    Xu H; Zhang Y; Altomare D; Peña MM; Wan F; Pirisi L; Creek KE
    Carcinogenesis; 2014 Jun; 35(6):1379-88. PubMed ID: 24574515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma.
    Hong D; Liu T; Huang W; Liao Y; Wang L; Zhang Z; Chen H; Zhang X; Xiang Q
    Cell Physiol Biochem; 2018; 47(5):1785-1799. PubMed ID: 29953975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
    Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
    Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
    Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
    Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.
    Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS
    Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
    Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
    Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma.
    Iguchi T; Ueda M; Masuda T; Nambara S; Kidogami S; Komatsu H; Sato K; Tobo T; Ogawa Y; Hu Q; Saito T; Hirata H; Sakimura S; Uchi R; Hayashi N; Ito S; Eguchi H; Sugimachi K; Maehara Y; Mimori K
    Oncology; 2018; 95(3):179-187. PubMed ID: 29909415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple roles of single-minded 2 in esophageal squamous cell carcinoma and its clinical implications.
    Tamaoki M; Komatsuzaki R; Komatsu M; Minashi K; Aoyagi K; Nishimura T; Chiwaki F; Hiroki T; Daiko H; Morishita K; Sakai Y; Seno H; Chiba T; Muto M; Yoshida T; Sasaki H
    Cancer Sci; 2018 Apr; 109(4):1121-1134. PubMed ID: 29427302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
    Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
    Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma.
    Gholamin M; Moaven O; Memar B; Farshchian M; Naseh H; Malekzadeh R; Sotoudeh M; Rajabi-Mashhadi MT; Forghani MN; Farrokhi F; Abbaszadegan MR
    World J Surg; 2009 Jul; 33(7):1439-45. PubMed ID: 19440651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podoplanin-mediated TGF-β-induced epithelial-mesenchymal transition and its correlation with bHLH transcription factor DEC in TE-11 cells.
    Wu Y; Liu Q; Yan X; Kato Y; Tanaka M; Inokuchi S; Yoshizawa T; Morohashi S; Kijima H
    Int J Oncol; 2016 Jun; 48(6):2310-20. PubMed ID: 27035755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.